Oracle Launches Life Sciences AI Data Platform to Boost Research and Development

Wedoany.com Report on Feb 3rd, Oracle has launched the Oracle Life Sciences AI Data Platform, which utilizes generative artificial intelligence technology, aiming to support organizations in pharmaceuticals, medical devices, research, and life sciences to enhance efficiency in R&D, clinical trials, post-market surveillance, and commercialization.

This Life Sciences AI Data Platform integrates customer data, third-party resources, and over 129 million de-identified Oracle Health real-world data records. Through unified and automated processing, it supports AI-based research. The platform employs generative AI and agent reasoning technologies to accelerate data interpretation and directly generate actionable evidence within research and clinical workflows.

Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, stated: "Data fragmentation and lack of standardization are major challenges hindering industry progress, impacting life sciences organizations' ability to drive medical advances that could improve or even save lives. The Oracle Life Sciences AI Data Platform intelligently integrates data and leverages AI and advanced analytical methods to uncover deep insights that are often difficult to obtain manually."

Leveraging pre-built AI agents and custom agent capabilities, users can identify label expansion potential, conduct population-level health economics and outcomes research, build synthetic control arms, monitor safety from diverse sources, and assist with regulatory submissions with greater efficiency and flexibility. Researchers can also pose open-ended questions; AI agents will clarify intent to form and refine hypotheses, provide analysis recommendations for evaluation, and execute tasks within user-defined parameters while ensuring complete data lineage transparency. This helps organizations expand research capabilities, explore new opportunities, optimize the effectiveness of existing therapies, and create measurable commercial value.

Oracle's various life sciences innovations are designed to seamlessly integrate with this unified data platform. By utilizing Oracle Cloud Infrastructure, the Oracle Life Sciences AI application suite, Oracle Fusion Cloud Supply Chain and Sales solutions, and the Oracle Health AI application suite, integrated operations are achieved, enabling life sciences organizations to fully leverage the advantages of the broader, interoperable Oracle ecosystem.